Maze Therapeutics, Inc. Entity Common Stock, Shares Outstanding
Financial Statements › Balance Sheet › Equity
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-05: Entity Common Stock, Shares Outstanding 55.55M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 55.35M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 48.12M shares.
- 2025-08-06: Entity Common Stock, Shares Outstanding 43.85M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-05 | 55.55M shares 10-Q · filed 2026-08-11 |
| 2026-05-07 | 55.35M shares 10-Q · filed 2026-05-12 |
| 2025-11-03 | 48.12M shares 10-Q · filed 2025-11-06 |
| 2025-08-06 | 43.85M shares 10-Q · filed 2025-08-12 |
| 2025-05-08 | 43.80M shares 10-Q · filed 2025-05-14 |